FPF
LKFT

FNY Partners Fund’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

FNY Partners Fund’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,200
Closed -$1.89M – 393
2017
Q4 		$1.89M Buy
20,200
+3,000
+17% +$284K 0.31% 46
2017
Q3 		$1.75M Buy
17,200
+2,700
+19% +$236K 0.3% 45
2017
Q2 		$1.11M Buy
14,500
+13,400
+1,218% +$1.13M 0.27% 42
2017
Q1 		$94K Buy
+1,100
New +$79.2K 0.01% 532

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FNY Partners Fund's LKFT Position: Q1 2018 in Review

FNY Partners Fund sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2018, closing a stake of 20,200 shares — an estimated $1.89M sold.

FNY Partners Fund first reported a position in LKFT in Q1 2017 and held it in 4 quarters. The position peaked at $1.89M in Q4 2017. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2018.

  • FNY Partners Fund reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • FNY Partners Fund sold 20,200 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2018, an estimated $1.89M.
  • FNY Partners Fund first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2017 and held it in 4 quarters.
  • FNY Partners Fund's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.89M in Q4 2017.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.